Invention Grant
- Patent Title: Fusion protein having factor VII activity
-
Application No.: US15080757Application Date: 2016-03-25
-
Publication No.: US10696960B2Publication Date: 2020-06-30
- Inventor: In-Young Song , Hun-Taek Kim , Bong-Yong Lee , Mahn-Hoon Park , Ho-Soon Lee , Yun Jung Lim , Ji-Hye Lee , Seo Yeon Son , Min-Sun Kim
- Applicant: TiumBio Co., Ltd.
- Applicant Address: KR Gyeonggi-Do
- Assignee: TiumBio Co., Ltd.
- Current Assignee: TiumBio Co., Ltd.
- Current Assignee Address: KR Gyeonggi-Do
- Agency: Alston & Bird LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2160f274
- Main IPC: C07K14/79
- IPC: C07K14/79 ; C12N9/64

Abstract:
A fusion protein comprising factor VII (FVII) and transferrin according to the present invention has an improved specific activity of FVII compared to existing FVII fusion proteins comprising other fusion partners than transferrin, and thus can be effectively used in a therapy using FVII.
Public/Granted literature
- US20160194622A1 FUSION PROTEIN HAVINGH FACTOR VII ACTIVITY Public/Granted day:2016-07-07
Information query